SynthesisJournal of ovarian research2023

Dose-dense regimen versus conventional three-weekly paclitaxel combination with carboplatin chemotherapy in first-line ovarian cancer treatment: a systematic review and meta-analysis.

Wenjian Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.